Education
About Us
Working with TipRanks
Follow Us
Entheon Biomedical (ENTBF)
OTHER OTC:ENTBF
ENTBF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.02 - $0.29
Previous CloseN/A
Volume3.65K
Average Volume (3M)504.00
Market Cap
$1.30M
Enterprise Value$2.72M
Total Cash (Recent Filing)C$249.92K
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta1.36
Next Earnings
Apr 25, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding13,858,926
10 Day Avg. Volume247
30 Day Avg. Volume504
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)6.37
Price to Cash Flow (P/CF)-4.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Entheon Biomedical News
PremiumCompany Announcements
Entheon Biomedical Announces Board Changes
PremiumCompany Announcements
Entheon Biomedical Grants Incentive Stock Options to Directors
PremiumCompany Announcements
Entheon Biomedical Ends Acquisition Agreement with Mentis AI
PremiumCompany Announcements
Entheon Biomedical Secures $500,000 in Private Placement
PremiumCompany Announcements
Entheon Biomedical Announces New Private Placement FinancingPremiumCompany Announcements
Entheon Biomedical Completes $147.5K Private PlacementPremiumCompany Announcements
Entheon Biomedical’s Strategic Financing Initiative---
Options Prices
Currently, No data available
---
Ownership Overview
ENTBF FAQ
What was Entheon Biomedical’s price range in the past 12 months?
Entheon Biomedical lowest stock price was $0.02 and its highest was $0.29 in the past 12 months.
What is Entheon Biomedical’s market cap?
Entheon Biomedical’s market cap is $1.30M.
When is Entheon Biomedical’s upcoming earnings report date?
Entheon Biomedical’s upcoming earnings report date is Apr 25, 2025 which is in 2 days.
How were Entheon Biomedical’s earnings last quarter?
Entheon Biomedical released its earnings results on Mar 05, 2025. The company reported -$0.009 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.009.
Is Entheon Biomedical overvalued?
According to Wall Street analysts Entheon Biomedical’s price is currently Overvalued.
Does Entheon Biomedical pay dividends?
Entheon Biomedical does not currently pay dividends.
What is Entheon Biomedical’s EPS estimate?
Entheon Biomedical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Entheon Biomedical have?
Entheon Biomedical has 13,858,926 shares outstanding.
What happened to Entheon Biomedical’s price movement after its last earnings report?
Entheon Biomedical reported an EPS of -$0.009 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Entheon Biomedical?
Currently, no hedge funds are holding shares in ENTBF
---
Company Description
Entheon Biomedical
Entheon Biomedical Corp is a biotechnology research and development company. It is committed towards developing and safe and effective psychedelic medicines in order to provide patients with access to evidence-based treatments for addiction disorders. It generates revenue through the sale of products to physicians, clinics and licensed psychiatrists in the United States, certain countries in the European Union and throughout Canada.
---
Technical Analysis
Numinus Wellness
―
Neo Performance Materials Inc
―
Cybin
―
Red Light Holland
―
HAVN Life Sciences
―
---